Mar 2–8

GENB led the week with a striking $150M insider cluster of four buyers including a 10% owner, while fellow biotech LRMR saw four insiders deploy $25.5M in a similar pattern. Six additional clusters emerged across financials and software, but biotech's outsized activity dominated the $188M total insider spending. This was a notably active week driven by concentrated buying in early-stage therapeutics.